ICML 2017 | Top follicular lymphoma discussion points at ICML 2017

Andrew Lister

Andrew Lister, MD from Barts Cancer Institute, London, UK provides his follicular lymphoma highlights from the International Conference on Malignant Lymphoma (ICML) 2017, Lugano, Switzerland. Prof. Lister discusses a number of the presentations given during the meeting. One presentation in particular, on the long-term follow up of initial treatments for advanced follicular lymphoma, sparked good debate on whether R-CHOP is the best first-line treatment. Prof. Lister goes on to discuss the role of rituximab as a maintenance therapy as well as data on pattern of survival in follicular lymphoma.
This video has been supported by Napp Pharmaceuticals Ltd through an unrestricted educational grant to Magdalen Medical Publishing.

Share this video